Breaking News, Promotions & Moves

Alkermes Names Joshua Reed Chief Financial Officer

With over 30 years of experience, Reed will advance strategic priorities, operations, and promote long-term growth.

By: Rachel Klemovitch

Assistant Editor

Alkermes appointed Joshua Reed as Chief Financial Officer (CFO), effective Monday, Sept. 15, 2025. Reed will report to Richard Pops, Chief Executive Officer of Alkermes, and will join the company’s management committee. Reed brings over 30 years of financial leadership experience, with a strong focus in the biotechnology and pharmaceutical sectors. He currently serves on the board of directors of Scholar Rock Holding Corporation Most recently, he served as CFO of Omega Therapeutics; ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters